Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep542 | Diabetes therapy | ECE2016

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

Sonmez Alper , Dinc Mustafa , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Haymana Cem , Demir Orhan , Azal Omer

Introduction: Intensive insulin treatment in obese patients with type 2 diabetes (T2DM) is often difficult. Insulin dosages are much higher, which further increase weight gain and the risk of hypoglycemia. Glucagon like peptide 1 receptor agonists (GLP-1RAs) are the promising treatment modalities causing weight loss and reducing the risk of hypoglycemia. There is no published data about the effect of adding on GLP1RAs to obese T2DM patients with un-controlled glucose levels un...

ea0029p1047 | Male Reproduction | ICEECE2012

Visceral adiposity index and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism

Haymana C. , Sonmez A. , Aydogdu A. , Taslipinar A. , Meric C. , Basaran Y. , Baskoy K. , Tapan S. , Uckaya G. , Bolu E. , Azal O.

Introduction: Visceral adipose tissue (VAT) is closely related to metabolic derangement, such as dyslipidemia insulin resistance and type 2 diabetes. Also, there is an increase in deposition of visceral adipose tissue in hypogonadal subjects. The visceral adiposity index (VAI) is a sex-specific mathematical index, based on waist circumference (WC), body mass index (BMI), triglycerides (TG) and HDL cholesterol (HDL) levels, indirectly expressing visceral adipose function. We in...

ea0022p697 | Obesity | ECE2010

Waist circumference does not reflect body fat distribution and insulin resistance in young male patients with idiopathic hypogonadotrophic hypogonadism

Aydogdu Aydogan , Kucukerdonmez Ozge , Uckaya Gokhan , Taslipinar Abdullah , Bolu S Erol , Sonmez Y Alper , Aydogan Umit , Kutlu Mustafa

Hypogonadism is associated with increased body fat content and insulin resistance. Many associations including ADA, IDF and EASD declare that waist circumference is a reliable measure of visceral adiposity and may account for insulin resistance. Our observations in young male patients with idiopathic hypogonadotrophic hypogonadism (IHH) are opposite. Thus, we aimed to compare body fat content and anthropometric measurements between patients and age-matched eugonadal healthy co...

ea0020p240 | Bone/Calcium | ECE2009

The effect of short term human chorionic gonadotropin treatment on the improvement of bone mass in patients with hypogonadotropic hypogonadism

Bolu Erol , Sonmez Alper , Apikoglu Mehmet , Gurel Hasan , Emer Ozdes , Taslipinar Abdullah , Ozguven M Ali , Kutlu Mustafa

Background: Idiopatic hypogonadotropic hypogonadism is a congenital abnormality due to GnRH deficiency which is associated with severe osteoporosis. Testosterone replacement has been shown to improve the loss in the bone mass. The aim of the present retrospective analysis was to measure the effect of human chorionic gonadotropin treatment on the improvement of bone mineral density.Methods: A total number of 96 young male (mean age 21±3.7 years) pati...

ea0020p367 | Diabetes and Cardiovascular | ECE2009

The relationship between hemoglobin levels and endothelial functions in diabetes mellitus

Sonmez Alper , Yilmaz M Ilker , Zoccali Carmine , Saglam Mutlu , Kilic Selim , Uckaya Gokhan , Eyileten Tayfun , Yenicesu Mujdat , Kutlu Mustafa

Introduction: Hemoglobin (Hb) is the main carrier and buffer of Nitric oxide. Recently, an inverse association between Hb and the endothelium dependent relaxation was observed in patients with Type 2 diabetes. Testing whether this association exists also in diabetic nephropathy is important because anemia in these patients starts at an earlier stage than in other renal disease. Also, at population level diabetes and renal dysfunction, particularly albuminuria, contribute indep...

ea0020p391 | Diabetes and Cardiovascular | ECE2009

Visfatin seems not to be related in insulin resistance

Taslipinar Abdullah , Taslipinar Mine Y , Azal Omer , Kebapcilar Levent , Sahin Mustafa , Uckaya Gokhan , Sonmez Y Alper , Kucukerdonmez Ozge , Kutlu Mustafa

Visfatin is a newly discovered adipocyte hormone. Recent studies showed a possible relationship between diabetes mellitus and visfatin level. But the effect of visfatin on the insulin resistance was not well understood. The aim of the present study was to explore the relation of visfatin with insulin resistance in patients with prediabetes and diabetes.We included a total of 128 persons in the study and of these 128 persons, 36 were diabetic, 69 were pre...

ea0020p492 | Obesity and Metabolism | ECE2009

The influence of weight lose on immune system

Yazici Mahmut , Engin Gok Deniz , Pekel Aysel , Tapan Serkan , Sonmez Yusuf Alper , Musabak Ugur , Bolu Sinasi Erol , Kutlu Mustafa

Aim: The prevalence of overweight and obesity is increasing and becoming a global health problem. Obesity is the cause of increased cardiovascular morbidity and mortality and psychosocial problems. There are several reports which mentioning the unfavourable effects of aggressive weight loss regimes on the immune system. This study was designed to search for the effect of a straightforward, controlled and permanent weight loss program on the immune system.<p class="abstext"...

ea0056p566 | Obesity | ECE2018

Does follicle stimulating hormone effect adiposity in patients with hypergonadotrophic hypogonadism: a retrospective study

Demirci Ibrahim , Haymana Cem , Gulcelik Nese Ersoz , Sonmez Yusuf Alper , Meric Coskun , Aydogdu Aydogan , Demir Orhan , Azal Omer

Introduction: Recent studies showed that post-menopausal osteoporosis and weight gain starts at the perimenopause stage, a period characterized by relatively stable estrogen and rising FSH levels. FSH is found to be associated with adiposity in women, which is also a great risk factor for type 2 DM. There is also a sharp increase in visceral adiposity during this life stage, which coincides with the emergence of disrupted energy balance and reduced physical activity. There is ...

ea0056p962 | Male Reproduction | ECE2018

Hematological indices in congenital hypogonadism and the effect of testosterone replacement therapy: A retrospective study

Haymana Cem , Demirci Ibrahim , Dinc Mustafa , Demir Orhan , Akin Onur , Meric Coskun , Aydogdu Aydogan , Sonmez Alper , Azal Omer

Introduction: Patients with hypogonadism are at increased risk for cardiovascular diseases. Mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) are hematological indices that are surrogate markers of adverse cardiovascular outcomes. This study investigated the platelet count, MPV levels, PLR, and NLR in patients with congenital hypogonadotrophic hypogonadism (CHH) and also studied the effect of testosterone replacement thera...

ea0049ep362 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Identifiying underdiagnosed or undertreated patients with familial hypercholesterolemia from the central laboratory registries

Haymana Cem , Berlik Hamza , Gunes Yalcin , Tuncez Orhan Enes , Aytekin Cihat , Tapikara Zafer , Guzel Huseyin , Ozturk Ozlem , Barcin Cem , Ozgurtas Taner , Azal Omer , Sonmez Alper

Objective: Familial hypercholesterolemia (FH) is a life-threatening genetic disease associated with elevated low density lipoprotein cholesterol (LDL-C) and premature coronary heart disease that is globally underdiagnosed and undertreated. This study aimed to search for the demographical characteristics, awareness and treatment adherence of underdiagnosed or undertreated FH patients from the records of the central biochemistry laboratory.Methods: Patient...